Suicidal Ideation Clinical Trial
— DEPIMPULSEOfficial title:
Controlled Randomized Non-comparative Trial Assessing Active Transcranial Direct Current Stimulation [tDCS] on Left Dorsoleteral Prefrontal Cortex Versus Active tDCS Active on Right Orbitofrontal Cortex to Treat Unipolar Depression
The study aims at investigating if tDCS applied to left DLPFC or to right OFC to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | February 2026 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Man or woman older than 18 years oldRight-handed - Signed Informed Consent form - Subject affiliated to or beneficiary from a French social security regime - Inpatient or outpatient at the Adult Psychiatry Service - Diagnosis of Major Depressive Disorder according to the 5th edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria and confirmation by the MINI Structured Clinical Interview - MADRS score = 18 - Beck Scale for Suicide Ideation (BSS) score =8 - Under antidepressant treatment - Absence of severe progressive neurologic and/or somatic pathologies (specially tumors, degenerative diseases) Exclusion Criteria: - tDCS contraindication - Younger than 18 years old - Left-handed - under mood stabilizer and/or antiepileptic - treated by ECT or rTMS or tDCS for the current eposide - Subject under measure of protection or guardianship of justice - Presence of other psychiatric pahtologies - Subject beneficiary from a legal protection regime - Subject unlikely to cooperate or low cooperation stated by investigator - Subject not covered by social security - Pregnant woman - Subject being in the exclusion period of another study or provided for by the "National Volunteer File" |
Country | Name | City | State |
---|---|---|---|
France | CHU de Besançon | Besançon | |
France | CHU de Clermont-Ferrand | Clermont-Ferrand | |
France | Hôpital Chenevier, GH Henri Mondor | Créteil | |
France | CHU de Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Besancon | Fondation FondaMental |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BSS scores | Difference of Beck's Scale for Suicide Ideation [BSS] score between Day 0 and Day 5, and between the arm active tDCS on left DLPFC and the arm active tDCS on right COF.
This scale contains 19 items to assess the risk level for suicide among general population. French version of this scale is designed for autovaluation. Each item is quoted from 0 (no suicidal thoughts) to 2 (high degrees of suicidal intent). |
Baseline (Day 0), Day 5 (D5) | |
Secondary | BSS scores | Difference of Beck's Scale for Suicide Ideation [BSS] score between Day 0 and Day 5, +W2 and +W4 between the 3 arms This scale contains 19 items to assess the risk level for suicide among general population. French version of this scale is designed for autovaluation.
Each item is quoted from 0 (no suicidal thoughts) to 2 (high degrees of suicidal intent). |
Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | C-SSRS scores | Compared scores from the Columbia-Suicide Severity Rating Scale (C-SSRS). The C-SSRS is a clinician-rated tool that evaluates suicidal ideation and behavior. It is composed by 6 "yes/no" questions. High suicide risk is indicated when "yes" is answered to questions 4, 5 or 6. | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | BIS-10 scores | Compared scores from the French version of the Barratt Impulsiveness Scale (BIS-10). The French version of the BIS-10 is a self-rated 34 item questionnaire, composed by three subscales: motor-impulsivity, cognitive-impulsivity and non-planning-impulsivity. Each item is scored on a 0 to 4 points scale. Higher scores indicate higher levels of impulsivity. | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | UPPS scores | Compared scores from the Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency Impulsive Behavior Scale (UPPS-P). The French version of the UPPS-P is a self-rated 45 item scale, evaluating the following components: urgency, lack of premeditation, lack of perseverance and sensation seeking. Each item is scored on a base of 4 points. Higher scores indicate higher levels of impulsivity. | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | BART scores | Balloon Analogue Risk Task (BART), assessing risk-taking behavior | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Cognitive assessment | Compared results from the experimental TEA, assessing cognitive functions. | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Delay discounting with MCQ scores | Compared scores from the French version of the Monetary Choice Questionnaire (MCQ). The MCQ is a self-rated 27 item questionnaire which assessed the discounting. Delay discounting is the decline in the present value of a reward with delay to its receipt.
Example item: " Would you prefer 25€ today or 75€ in 15 days? " For each item, subjects must choose between a low immediate reward and a higher delayed reward. Waiting times vary from 7 days to 186 days, and rewards are divided into 3 magnitudes: low (25-35€), medium (50-60€), high (75-85€). This will allow assessing: the influence of the the magnitude of the difference between the two rewards proposed, the impact of the time on the reward's subjective value (speed at which the reward is devalued over time), reflected in the k index. This index is calculated separately for each magnitude, and an average index is calculated for each subject. The more the k index is high, the more the subject is considered impulsive. |
Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Severity of depressive symptoms evaluated by the clinician | Score achieved on the validated clinician questionnaire Quick Inventory of Depressive Symptomatology (QIDS-C16) evaluating the severity of depressive symptoms.
The QIDS-C16 was derived from specified items in the IDS-C30, clinician-rated scale to assess the severity of a participant's depressive symptoms. Total scores range from 0-27, with a score of 0 indicating no depression and a score of 27 indicating the most severe depression. Negative change from baseline values indicate improvement in the severity of depression. |
Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Severity of depressive symptoms evaluated by the patient | Score achieved on the validated self-reported (QIDS-SR16) evaluating the severity of depressive symptoms. QIDS-SR-16 is a standard questionnaire "The Quick Inventory of Depressive Symptomatology" (16-Item) (Self-Report). This covers questions on falling asleep, sleep during the night, waking up , sleeping too much, feeling sad ,appetite, weight, concentration , how they view themselves, thoughts of death and suicide, general interests, energy levels, feeling slowed down , feeling restless. | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Quality of life measured with the EQ-5D-5L | Quality of life measured with the EQ-5D-5L | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS | |
Secondary | Psychological and Physical Pain-Visual Analogic Scale (PPP-VAS) | Likert scales from 0 (none) to 10 (maximum possible pain) | Baseline (Day 0), Day 5 (D5), Week 2(+W2) and Week 4 (+W4) post-tDCS |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05334381 -
Navigating Mental Health Treatment for Black Youth
|
N/A | |
Recruiting |
NCT04653337 -
Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression
|
Phase 2 | |
Terminated |
NCT04254809 -
Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts
|
N/A | |
Recruiting |
NCT05848089 -
Real-time Intervention for Suicide Risk Reduction
|
N/A | |
Recruiting |
NCT06322199 -
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
|
||
Completed |
NCT05280756 -
Home-based tDCS for Prevention of Suicidal Ideation
|
N/A | |
Not yet recruiting |
NCT06454136 -
Pilot Trial of Mobile Technology for Adolescent Suicidality
|
N/A | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Completed |
NCT02021344 -
Mental Health First Aid for College Students
|
N/A | |
Not yet recruiting |
NCT04686162 -
Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy
|
N/A | |
Recruiting |
NCT05377177 -
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
|
N/A | |
Completed |
NCT05580757 -
Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
|
||
Recruiting |
NCT05925322 -
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
|
N/A | |
Not yet recruiting |
NCT05427734 -
Treating Drivers of Suicide Using Jaspr Health
|
N/A | |
Recruiting |
NCT04112368 -
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
|
Phase 4 | |
Completed |
NCT04026308 -
Written vs Electronic Safety Planning Study
|
N/A | |
Recruiting |
NCT05537376 -
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
|
N/A | |
Not yet recruiting |
NCT06311591 -
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B
|
N/A | |
Not yet recruiting |
NCT05860257 -
Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction
|
N/A | |
Recruiting |
NCT05555927 -
Adjunctive Duration-doubled tDCS for the Treatment of Depressive Patients With Suicidal Ideation
|
N/A |